Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025

by Jonathan Hodson-Walker | May 1, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
Technology Private Placement and M&A Transactions Review Week Ending April 20, 2025

Technology Private Placement and M&A Transactions Review Week Ending April 20, 2025

by Jonathan Hodson-Walker | Apr 24, 2025 | Technology

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Auradine: The company raised $153 million of Series C venture funding in a deal led by StepStone Group on April 16, 2025. Samsung Catalyst Fund, Qualcomm Ventures, MARA holdings,...
Consumer Private Placement and M&A Transactions Review Week Ending April 20, 2025

Consumer Private Placement and M&A Transactions Review Week Ending April 20, 2025

by Jonathan Hodson-Walker | Apr 24, 2025 | Consumer

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions The Ryl Co.: The company raised $15 million of Series B venture funding from Cam Fordham, Alex Dermer and Ben Hiott on April 14, 2025. Austin Neal, Seth England and other undisclosed...
Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending April 20, 2025

by Jonathan Hodson-Walker | Apr 24, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Glycomine: The company raised $115 million of Series C venture funding in a deal led by Advent Life Sciences and CTI Life Sciences Fund on April 16, 2025. Chiesi Ventures, Novo...
Technology Private Placement and M&A Transactions Review Week Ending April 13, 2025

Technology Private Placement and M&A Transactions Review Week Ending April 13, 2025

by Jonathan Hodson-Walker | Apr 16, 2025 | Technology

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Safe Superintelligence: The company raised $2 billion of venture funding in a deal led by Greenoaks Capital Partners on April 13, 2025, putting the company’s pre-money...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives